Organic Active Ingredients TRIZ Cases

Conjugating modified nucleic acids with targeting ligands achieves specific cellular uptake while protecting the payload from nuclease degradation.

Curtius rearrangement synthesizes oleanane cinnamamide derivatives that preserve anti-tumor activity against cancer cells and reduce cardiomyocyte toxicity.

Alternative reducing agents replace toxic reagents to improve yield and stability while eliminating lengthy chromatographic purification steps.

Combines SARM1 inhibitors with DLK or NAMPT agents to maintain intracellular NAD+ levels.

Aqueous imatinib formulation enables targeted pulmonary delivery via inhalation.

Heterocyclic GLP-1 agonists stimulate insulin secretion and reduce glucagon levels to improve glucose homeostasis.

SHP1-inhibited dendritic cell vesicles boost antigen presentation to overcome dysfunctional cell limitations.

Conditional immortalization enables scalable exosome production from stable neural stem cell lines, overcoming supply limitations of primary sources.

Water-insoluble lipid coatings mask bitter taste while dissolving in the gastrointestinal tract to maintain bioavailability.

Conjugating withasteroids with indolealkylamino groups improves cognitive function while reducing hepatotoxicity and peripheral cholinergic side effects.

Novel 5-membered heteroarylcarboxamide derivatives inhibit plasma kallikrein, reducing retinal vascular permeability in diabetic retinopathy.

Enteric-coated minitablets within delayed-release capsules reduce gastric side effects while maintaining therapeutic efficacy.

Timed pulsatile release coating on solid dispersion beads manages pH-dependent solubility changes to ensure consistent plasma concentrations.

A recombinant fusion protein vaccine composition comprising specific streptococcal antigens to induce a robust immune response in horses.

Formula I indolines resolve safety and efficacy trade-offs in CETP inhibition by increasing HDL-C up to 138% while lowering LDL-C by 40%.

Conductive filler dissipates static charge during ethylcellulose film coating, enabling extended release profiles without agglomeration.

IL-1β inhibitors block inflammasome pathways to treat acute cystitis, addressing antibiotic resistance and chronic tissue damage.

Bicyclic heterocycle compounds bind to IAP protein BIR domains, disrupting anti-apoptotic protection and sensitizing resistant tumor cells to chemotherapy.

Macrocyclic compounds scavenge reactive oxygen species to prevent neuronal damage despite poor clinical translation from animal models.

2-Oxothiazole compounds inhibit phospholipase A2 enzymes, addressing the lack of effective inhibitors for chronic inflammatory disorders.

Tryptamine ureas sensitize Gram-negative bacteria to polymyxin antibiotics by modifying membrane permeability.

HDL-ApoM-S1P reduces amyloid beta and tau deposition, resolving limited cognitive improvement from standard anti-inflammatory treatments.

Fatty acid coating prevents drug absorption into rubber valves and stops particle aggregation in HFA propellants.

Isomyosmine modulates apoptosis and increases blood oxygen saturation, converting oxidative stress into protective signals that extend lifespan.

Aerosol delivery of interferon beta targets the lower respiratory tract to treat influenza infections.

Segmented phases deposit zinc pyrithione during rinsing, resolving the trade-off between routine compliance and active agent retention.

Replacing imidazole moieties with pyridine rings eliminates unfavorable biotransformations and extends half-life while maintaining receptor binding potency.

TLR4/MD-2 agonists reverse Type 1 diabetes by inducing endotoxin tolerance and preserving pancreatic beta cells.

Isoxazole-modified FAP inhibitors preserve neutral pH stability and reduce clinical toxicities.

A triazolopyridazine compound targets PIM family kinases with specific structural features.

Oral composition combining probiotic strains with guggul and green tea leaf extracts to reduce inflammatory lesions while balancing gut microbiome dysbiosis.

Auricularia auricula polysaccharides down-regulate PD-L1 expression, reducing adverse reactions and production costs of cancer therapies.

Ethoxydiglycol mediates stable delivery of vitamin C and polyamines into the skin, resolving formulation stability versus penetration depth trade-offs.

FSTL3 inhibitors reduce inflammatory cytokine expression to restore glucose metabolism in obesity.

Bifidobobacterium breve strain DSM 32356 protects against aspirin-induced small intestinal damage while preserving cardiovascular benefits.

Continuous estriol combined with periodic progestogen reduces relapse frequency and improves cognitive test scores in multiple sclerosis patients.

A non-covalent ABOA-human serum albumin complex creates a clear aqueous solution for intravenous drug delivery.

Cellulosic foam stabilizers create stable oral delivery systems that improve bioavailability and taste balance without complex binders.

Solamargine and solasonine in the Solanum extract reduce oxidative stress by inhibiting NF-kB expression, preventing chronic inflammation.

Targeting succinate signaling with oral films reduces bone loss and improves treatment accessibility for diabetic patients.

Wet granulation transforms powdery allulose into direct compression excipients, enabling high-content tablets without additional binders.

A fiber blend and probiotic mixture formulation supports gut microbiota stability through targeted fermentation.